ECP 2024 Final Programme

Sunday, 8 Sept 225 ECP 2024 Florence LS-03 Industry Symposium 13:00–14:30 Spadolini 3 Synergies in sight: navigating challenges of precision medicine via multidiscipli- nary collaboration in GU oncology Johnson&Johnson + Diatech Pharmacogenetics Chair: Gabriella Nesi, Italy 001 13:00–13:15 Diagnostic challenges and precision medicine in bladder cancer Gabriella Nesi, Italy 002 13:15–13:30 Current molecular landscape of bladder cancer: the oncologist’s perspective Brigida Anna Maiorano, Italy 003 13:30–13:40 Discussion/Q&A 004 13:40–13:55 Current considerations and challenges in prostate cancer testing Glen Kristiansen, Germany 005 13:55–14:10 Molecular testing in GU oncology: pitfalls and analytical strategies Rossella Bruno, Italy 006 14:10–14:30 Round table and Q&A LS-04 Industry Symposium 13:00–14:30 Spadolini 4 Beyond the human eye: diagnostic advances in digital and computational pathology AstraZeneca Chair: Luiza Moore, United Kingdom 001 13:00–13:05 Welcome & introduction Luiza Moore, United Kingdom 002 13:05–13:25 Seeing eye to (A)I: digital pathology is part of pathology Bethany Williams, United Kingdom 003 13:25–14:05 Problem-solving digital pathology: attitudes, issues and solutions Fabio Pagni, Italy Angelo Paolo Dei Tos, Italy 004 14:05–14:30 Quantitative continuous scoring: a new frontier in diagnostics – updates Luiza Moore, United Kingdom LS-05 Industry Symposium 13:00–14:30 Spadolini 5 Navigating precision pathology: bio- markers defining treatment, tissue and liquid biopsy synergy, and collaborative patient care MSD Chair: Matteo Fassan, Italy 001 13:00–13:05 Welcome & introduction Matteo Fassan, Italy 002 13:05–13:25 Biomarker breakthroughs to treatment transformations: unveiling the shifting landscape in upper GI cancer Matteo Fassan, Italy 003 13:25–13:45 Unlocking the potential of liquid biopsies: overcoming challenges in prostate cancer biomarker testing Albrecht Stenzinger, Germany 004 13:45–14:05 Building partnerships in precision medicine: a collaborative approach between medical oncologists and pathologists for patient management Kaikeen Shiu, United States 005 14:05–14:15 Panel discussion Matteo Fassan, Italy 006 14:15–14:30 Q&A and closing remarks Matteo Fassan, Italy Industry Symposia